Cellular antibody affinity-based CRISPR screening identifies JUNB as a broadly acting antiviral factor. Waild NC, Ciesla JH, Schafer XL, Munger J, et al. Proc Natl Acad Sci U S A 2026;123:e2534154123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Waild NC, Ciesla JH, Schafer XL, Munger J, et al. Cellular antibody affinity-based CRISPR screening identifies JUNB as a broadly acting antiviral factor. Proc Natl Acad Sci U S A 2026;123:e2534154123.
PMID: 41911457